Assessment of Clinical Risk Factors and Survival Outcomes in Postoperative Recurrence or Metastasis of Colorectal Cancer - Takeaways - MDSpire

Assessment of Clinical Risk Factors and Survival Outcomes in Postoperative Recurrence or Metastasis of Colorectal Cancer

  • By

  • Haoran Zhu

  • Yuankun Cai

  • ChongWei Ke

  • Huipeng Wang

  • February 24, 2026

  • 0 min

Share

  • 1

    Colorectal cancer accounts for 10% of new cancer cases globally, with a significant local recurrence rate post-surgery.

  • 2

    The 5-year survival rate for patients with recurrent colorectal cancer is less than 5%, highlighting the severity of recurrence.

  • 3

    A total of 419 patients were analyzed, with strict inclusion criteria ensuring accurate assessment of recurrence and metastasis.

  • 4

    Mesocolic fascia infiltration and neuroinvasion are critical pathological factors assessed for predicting recurrence in colorectal cancer.

  • 5

    Adjuvant chemotherapy was completed by 78.3% of patients, with treatment adherence impacted by adverse reactions and patient choices.

Original Source(s)

Assessment of Clinical Risk Factors and Survival Outcomes in Postoperative Recurrence or Metastasis of Colorectal Cancer

  • by Haoran Zhu, Yuankun Cai, ChongWei Ke, Huipeng Wang

  • February 24, 2026

Related Content

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”